BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21162720)

  • 1. Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.
    Klomp JA; Petillo D; Niemi NM; Dykema KJ; Chen J; Yang XJ; Sääf A; Zickert P; Aly M; Bergerheim U; Nordenskjöld M; Gad S; Giraud S; Denoux Y; Yonneau L; Méjean A; Vasiliu V; Richard S; MacKeigan JP; Teh BT; Furge KA
    BMC Med Genomics; 2010 Dec; 3():59. PubMed ID: 21162720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
    Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
    Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic.
    Enomoto Y; Namba Y; Hoshika Y; Komemushi Y; Mitani K; Kume H; Kobayashi E; Miyama Y; Homma Y; Ushiku T; Seyama K
    Eur J Med Genet; 2020 Apr; 63(4):103820. PubMed ID: 31778855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome.
    Benhammou JN; Vocke CD; Santani A; Schmidt LS; Baba M; Seyama K; Wu X; Korolevich S; Nathanson KL; Stolle CA; Linehan WM
    Genes Chromosomes Cancer; 2011 Jun; 50(6):466-77. PubMed ID: 21412933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birt-Hogg-Dube Syndrome with a Novel Mutation in the FLCN Gene.
    Kayhan G; Yılmaz Demirci N; Turktas H; Ergun MA
    Genet Test Mol Biomarkers; 2017 Oct; 21(10):632-634. PubMed ID: 28805452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
    Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
    Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic characteristics of Chinese patients with BHD syndrome and functional analysis of FLCN variants.
    Liu K; Xu W; Tian X; Xiao M; Zhao X; Zhang Q; Qu T; Song J; Liu Y; Xu KF; Zhang X
    Orphanet J Rare Dis; 2019 Oct; 14(1):223. PubMed ID: 31615547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Birt-Hogg-Dubé syndrome: an update].
    López V; Jordá E; Monteagudo C
    Actas Dermosifiliogr; 2012 Apr; 103(3):198-206. PubMed ID: 21937013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral peripheral small papillary tufts: a diagnostic clue of renal tumors associated with Birt-Hogg-Dubé syndrome.
    Kuroda N; Furuya M; Nagashima Y; Gotohda H; Moritani S; Kawakami F; Imamura Y; Bando Y; Takahashi M; Kanayama HO; Ota S; Michal M; Hes O; Nakatani Y
    Ann Diagn Pathol; 2014 Jun; 18(3):171-6. PubMed ID: 24767893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutional FLCN mutations in patients with suspected Birt-Hogg-Dubé syndrome ascertained for non-cutaneous manifestations.
    Maffé A; Toschi B; Circo G; Giachino D; Giglio S; Rizzo A; Carloni A; Poletti V; Tomassetti S; Ginardi C; Ungari S; Genuardi M
    Clin Genet; 2011 Apr; 79(4):345-54. PubMed ID: 20618353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of renal tumors associated with Birt-Hogg-Dubé syndrome with focus on clinical and pathobiological aspects.
    Kuroda N; Furuya M; Nagashima Y; Gotohda H; Kawakami F; Moritani S; Ota S; Hora M; Michal M; Hes O; Nakatani Y
    Pol J Pathol; 2014 Jun; 65(2):93-9. PubMed ID: 25119168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide Uniparental Disomy and Copy Number Variations in Renal Cell Carcinomas Associated with Birt-Hogg-Dubé Syndrome.
    Iribe Y; Yao M; Tanaka R; Kuroda N; Nagashima Y; Nakatani Y; Furuya M
    Am J Pathol; 2016 Feb; 186(2):337-46. PubMed ID: 26776076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic insight into Birt-Hogg-Dubé syndrome in Indian patients reveals novel mutations at FLCN.
    Ray A; Chattopadhyay E; Singh R; Ghosh S; Bera A; Sarma M; Munot M; Desai U; Rajan S; Prabhudesai P; Prakash AK; Roy Chowdhury S; Bhowmick N; Dhar R; Udwadia ZF; Dey A; Mitra S; Joshi JM; Maitra A; Roy B
    Orphanet J Rare Dis; 2022 Apr; 17(1):176. PubMed ID: 35477461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relevance of Family History Taking in the Detection and Management of Birt-Hogg-Dubé Syndrome.
    Torricelli E; Occhipinti M; Cavigli E; Tancredi G; Rosi E; Rossi C; Bonaguro M; Candita L; Papi L; Novelli L; Bezzi M; Bargagli E; Voltolini L; Pistolesi M
    Respiration; 2019; 98(2):125-132. PubMed ID: 31266032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploinsufficiency of the folliculin gene leads to impaired functions of lung fibroblasts in patients with Birt-Hogg-Dubé syndrome.
    Hoshika Y; Takahashi F; Togo S; Hashimoto M; Nara T; Kobayashi T; Nurwidya F; Kataoka H; Kurihara M; Kobayashi E; Ebana H; Kikkawa M; Ando K; Nishino K; Hino O; Takahashi K; Seyama K
    Physiol Rep; 2016 Nov; 4(21):. PubMed ID: 27905298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome.
    Furuya M; Hasumi H; Baba M; Tanaka R; Iribe Y; Onishi T; Nagashima Y; Nakatani Y; Isono Y; Yao M
    Lab Invest; 2017 Mar; 97(3):343-351. PubMed ID: 27991910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
    Benusiglio PR; Giraud S; Deveaux S; Méjean A; Correas JM; Joly D; Timsit MO; Ferlicot S; Verkarre V; Abadie C; Chauveau D; Leroux D; Avril MF; Cordier JF; Richard S;
    Orphanet J Rare Dis; 2014 Oct; 9():163. PubMed ID: 25519458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
    Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
    Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel FLCN Variant in a Suspected Birt-Hogg-Dubè Syndrome Patient.
    Bandini E; Zampiga V; Cangini I; Ravegnani M; Arcangeli V; Rossi T; Mammi I; Schiavi F; Zovato S; Falcini F; Calistri D; Danesi R
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.